From Plants, UVA Extracts a Better Way to Determine What Our Genes Do
The improved technique will help explore genetic diseases and benefit drug development. It could also lead to better, safer weed killers.
Read more
Drug Development
National Cancer Institute awards UCLA prostate cancer program with Research of Excellence grant
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
Read more
IU School of Medicine awarded $36 million NIH grant for Alzheimer’s disease drug discovery center
The IU-led center is one of only two multi-institution teams in the nation selected as part of a new federal program intended to improve, diversify and reinvigorate the Alzheimer’s disease drug development pipeline.
Read moreLatest Global Immuno-Oncology Landscape Report from the Cancer Research Institute Published in Nature Reviews Drug Discovery
Cancer Research Institute analysis of the global immuno-oncology landscape shows dramatic two-year growth in therapeutic targets and I-O drugs in clinical development
Read more
Getting New Medical Treatments to Patients Can be Harder Than Landing on Mars
It takes about 10 years and $100 million to get a new medical device to market – $1 billion for a new drug. Most new solutions fail. The biggest foils are not the science or pre-clinical trials but the lack of finances, market miscalculation, bad business models, and regulatory snags. They can all be overcome.
Read more